rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1995-3-1
|
pubmed:abstractText |
More than 90% of the major histocompatibility complex (MHC) class II molecules on antigen-presenting cells (APC) have in their binding site a peptide derived from an extracellular protein ingested by the APC or from a protein of the APC itself. These self-peptides can be eluted from affinity-purified MHC class II molecules by acid elution, and have been studied with a variety of techniques. We show here that the self-peptides eluted from the mouse MHC class II molecules Ad, Ed and Ek bind specifically to MHC class II molecules of the allelic type from which they were derived. The pH optimum for binding is around 5.0, i.e. the same optimum at which synthetic peptides representing sequences of foreign antigens bind to MHC class II molecules. This suggests that the physiological compartment where MHC class II molecules bind self-peptides may be very late in the endocytic pathway. The chemical properties of the eluted and labelled MHC class II peptides were studied by isoelectric focusing. This method was able to separate the peptides very efficiently, and enabled a rapid comparison of peptides eluted from different MHC molecules. The 125I-labelled peptides displayed a broad range of isoelectric points with values predominantly below neutral. This suggests that such peptides bind to MHC in a predominantly non-charged state.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1319610,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1323877,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1328884,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1380674,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1381392,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1512543,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1525820,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1538129,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1546328,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1656278,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1700304,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1709722,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1718025,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1730877,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1763019,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1829108,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1847504,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1899049,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-1922338,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-2332737,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-2413457,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-2480524,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-2783704,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-3194755,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-3490919,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-4747963,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-7334174,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-8145819,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-8316295,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-8409381,
http://linkedlifedata.com/resource/pubmed/commentcorrection/7835915-8419482
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0019-2805
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
529-34
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:7835915-Amino Acid Sequence,
pubmed-meshheading:7835915-Animals,
pubmed-meshheading:7835915-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:7835915-Histocompatibility Antigens Class II,
pubmed-meshheading:7835915-Hydrogen-Ion Concentration,
pubmed-meshheading:7835915-Isoelectric Focusing,
pubmed-meshheading:7835915-Mice,
pubmed-meshheading:7835915-Mice, Inbred Strains,
pubmed-meshheading:7835915-Molecular Sequence Data,
pubmed-meshheading:7835915-Muramidase,
pubmed-meshheading:7835915-Peptide Fragments
|
pubmed:year |
1994
|
pubmed:articleTitle |
MHC class II-bound self-peptides can be effectively separated by isoelectric focusing and bind optimally to their MHC class II restriction elements around pH 5.0.
|
pubmed:affiliation |
Institute for Medical Microbiology and Immunology, University of Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|